Trial intelligence / Profile preview

Bioequivalence study of trimetazidine dihydrochloride modified-release tablets under fed conditions in healthy Thai volunteers

TCTR20180928001Completed

Sponsor
All Research
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of trimetazidine in angina pectoris (2 arms), sponsored by All Research. Primary endpoints: Cmax, AUC0-t and 1 more. Started Dec 2018; status: completed.

02

Drugs

trimetazidine
03

Conditions

angina pectoris

Beyond the preview

Go deeper on TCTR20180928001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180928001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call